Filing Details

Accession Number:
0001415889-24-013935
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-21 16:13:38
Reporting Period:
2024-05-20
Accepted Time:
2024-05-21 16:13:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1472012 Immunome Inc. IMNM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1167496 B Clay Siegall C/O Immunome, Inc.
18702 N. Creek Parkway, Suite 100
Bothell WA 98011
President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-20 79,566 $13.91 399,202 No 4 P Direct
Common Stock Acquisiton 2024-05-21 20,434 $13.78 419,636 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The weighted average purchase price for the transaction report was $13.907,and the range of prices were between $13.77 and $13.99. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
  2. The weighted average purchase price for the transaction report was $13.7784, and the range of prices were between $13.62 and $13.99. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.